People who undergo a stem cell transplant or CAR T-cell therapy have an increased risk of infection after treatment. This presentation discusses who’s at risk, when infections typically arise, steps taken by transplant teams to avoid and treat infections and steps patients can take to reduce their risk of developing a serious infection.

The chemotherapy and/or radiation given to patients before a stem cell transplant compromise immunity and leave patients vulnerable to infections. This presentation describes major infection risks and effective responses to them. Many thanks to Takeda Pharmaceutical Company whose support, in part, made this presentation possible.

Bone marrow, stem cell and cord blood transplant recipients have an increased risk of infection until their immune system has fully recovered, which can take many months. This presentation reviews the types of infections transplant recipients often acquire and ways to prevent and treat them.